XENETIC BIOSCIENCES, INC. (XBIO) Operating margin 2016–2025
XENETIC BIOSCIENCES, INC. (XBIO) operating margin by fiscal year — reported operating income divided by reported revenue.
-95.2%FY2025 · since FY2016: -1581.0% → -95.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -95.2% | +72.9 pp |
| FY2024 | -168.2% | +9.6 pp |
| FY2023 | -177.8% | +215.8 pp |
| FY2022 | -393.6% | +101.5 pp |
| FY2021 | -495.1% | +2694.7 pp |
| FY2020 | -3189.8% | +72321.9 pp |
| FY2019 | -75511.7% | — |
| FY2017 | -47.1% | +1534.0 pp |
| FY2016 | -1581.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice